Quintás-Cardama, A., Kantarjian, H., Shan, J., Jabbour, E., Abruzzo, L. V., Verstovsek, S., . . . Cortes, J. (2011). Prognostic Impact of Deletions of Derivative Chromosome 9 in Patients With Chronic Myelogenous Leukemia Treated With Nilotinib or Dasatinib. Cancer.

Quintás-Cardama, Alfonso, Hagop Kantarjian, Jianqin Shan, Elias Jabbour, Lynne V. Abruzzo, Srdan Verstovsek, Guillermo Garcia-Manero, Susan O'Brien, and Jorge Cortes. "Prognostic Impact of Deletions of Derivative Chromosome 9 in Patients With Chronic Myelogenous Leukemia Treated With Nilotinib or Dasatinib." Cancer 2011.

Quintás-Cardama, Alfonso, et al. "Prognostic Impact of Deletions of Derivative Chromosome 9 in Patients With Chronic Myelogenous Leukemia Treated With Nilotinib or Dasatinib." Cancer 2011.